| abstract |
An object of the present invention is to provide a compound having a specific chemical structure or a pharmacologically acceptable salt thereof having an excellent inhibitory effect on EZH1 and/or EZH2 activity. A compound having a 1,3-benzodioxole structure represented by the general formula (I), a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing such a compound. (Here, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 and V in formula (I) have the same definitions and definitions in the specification, respectively). |